Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

Clinical trial NCT02228681 · COMPLETED

Trial details

NCT number: NCT02228681
Sponsor: GOG Foundation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced, Persistent, or Recurrent Endometrial Cancer

Start date: 2015-05-21
Primary completion: 2018-01-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.